Help on way for attention deficit hyperactivity disorder sufferers

PEOPLE diagnosed with attention deficit hyperactivity disorder (ADHD) may receive a little relief to the hip pocket following a $10 million investment from the Australian Government. From March 1, Intuniv (guanfacine) for the treatment of ADHD will be made available as an add-on therapy to other ADHD medicines on the Pharmaceutical Benefits Scheme (PBS). Without […]

Subscribe or Login to see the rest of the content.

Digital Editions


  • Gender equality on target

    Gender equality on target

    SWAN Hill Rural City Council has reported a 97 per cent completion rate on its four-year Gender Equality Action Plan, with almost every target achieved…